Skip to main content
Top
Published in: The European Journal of Health Economics 1/2013

Open Access 01-07-2013 | Original Paper

Lead versus lag-time trade-off variants: does it make any difference?

Authors: Federico Augustovski, Lucila Rey-Ares, Vilma Irazola, Mark Oppe, Nancy J. Devlin

Published in: The European Journal of Health Economics | Special Issue 1/2013

Login to get access

Abstract

Objectives

The traditional time trade-off (TTO) method has some problems in the valuation of health states considered worse than dead. The aim of our study is to compare two TTO variants that address this issue: lead-time and lag-time TTO.

Methods

Quota sampling was undertaken in June 2011 in Buenos Aires as part of the EQ-5D-5L Multinational Pilot Study. Respondents were randomly assigned to one of the TTO variants with two blocks of five EQ-5D-5L health states. Tasks were administered using a web-based digital aid (EQ-VT) administered in a group interview.

Results

A total of 387 participants were included [mean age 38.85 (SD: 13.97); 53.14 % females]. The mean observed values ranged from 0.44 (0.59) for state 21111 to 0.02 (0.76) for state 53555 in the lead-time group and between 0.53 (0.52) and 0.08 (0.76) in the lag-time group. There were no statistically significant differences in the values between TTO variants, except for a significant difference of 0.19 for state 33133. In both variants, marked peaks were observed around the value 0 across all states, with a higher percentage of 0 responses in the last state valued, suggesting ordering effects.

Conclusions

No important differences were found between TTO variants regarding values for EQ-5D-5L health states, suggesting that they could be equivalent variants. However, differences between the two methods may have been obscured by other aspects of the study design affecting the characteristics of the data.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Johnson, J.A., Coons, S.J., Ergo, A., Szava-Kovats, G.: Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 13(4), 421–433 (1998)PubMedCrossRef Johnson, J.A., Coons, S.J., Ergo, A., Szava-Kovats, G.: Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 13(4), 421–433 (1998)PubMedCrossRef
3.
go back to reference Hisashige, A., Mikasa, H., Katayama, T.: Description and valuation of health-related quality of life among the general public in Japan by the EuroQol. J Med Invest 45(1–4), 123–129 (1998)PubMed Hisashige, A., Mikasa, H., Katayama, T.: Description and valuation of health-related quality of life among the general public in Japan by the EuroQol. J Med Invest 45(1–4), 123–129 (1998)PubMed
4.
go back to reference Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15(10), 1121–1132 (2006). doi:10.1002/hec.1124 PubMedCrossRef Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., Busschbach, J.J.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15(10), 1121–1132 (2006). doi:10.​1002/​hec.​1124 PubMedCrossRef
6.
go back to reference Augustovski, F.A., Irazola, V.E., Velazquez, A.P., Gibbons, L., Craig, B.M.: Argentine valuation of the EQ-5D health states. Value Health 12(4), 587–596 (2009)PubMedCrossRef Augustovski, F.A., Irazola, V.E., Velazquez, A.P., Gibbons, L., Craig, B.M.: Argentine valuation of the EQ-5D health states. Value Health 12(4), 587–596 (2009)PubMedCrossRef
7.
go back to reference Tilling, C., Devlin, N., Tsuchiya, A., Buckingham, K.: Protocols for time tradeoff valuations of health states worse than dead: a literature review. Med. Decis. Making 30(5), 610–619 (2010)PubMedCrossRef Tilling, C., Devlin, N., Tsuchiya, A., Buckingham, K.: Protocols for time tradeoff valuations of health states worse than dead: a literature review. Med. Decis. Making 30(5), 610–619 (2010)PubMedCrossRef
8.
go back to reference Buckingham, K.J., Devlin, N.J.: A note on the nature of utility in time and health and implications for cost utility analysis. Soc. Sci. Med. 68(2), 362–367 (2009)PubMedCrossRef Buckingham, K.J., Devlin, N.J.: A note on the nature of utility in time and health and implications for cost utility analysis. Soc. Sci. Med. 68(2), 362–367 (2009)PubMedCrossRef
9.
go back to reference Craig, B.M., Oppe, M.: From a different angle: a novel approach to health valuation. Soc. Sci. Med. 70(2), 169–174 (2010)PubMedCrossRef Craig, B.M., Oppe, M.: From a different angle: a novel approach to health valuation. Soc. Sci. Med. 70(2), 169–174 (2010)PubMedCrossRef
10.
go back to reference Robinson, A., Spencer, A.: Exploring challenges to TTO utilities: valuing states worse than dead. Health Econ. 15(4), 393–402 (2006)PubMedCrossRef Robinson, A., Spencer, A.: Exploring challenges to TTO utilities: valuing states worse than dead. Health Econ. 15(4), 393–402 (2006)PubMedCrossRef
11.
go back to reference Devlin, N., Buckingham, K., Shah, K., Tsuchiya, A., Tilling, C., Wilkinson, B., van Hout, B.: A comparison of alternative variants of the lead and lag-time TTO. Paper presented at the 2010 Scientific Plenary of the EuroQol Group, Greece Devlin, N., Buckingham, K., Shah, K., Tsuchiya, A., Tilling, C., Wilkinson, B., van Hout, B.: A comparison of alternative variants of the lead and lag-time TTO. Paper presented at the 2010 Scientific Plenary of the EuroQol Group, Greece
12.
go back to reference Devlin, N.J., Tsuchiya, A., Buckingham, K., Tilling, C.: A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead-time’ approach. Health Econ. 20(3), 348–361 (2011)PubMedCrossRef Devlin, N.J., Tsuchiya, A., Buckingham, K., Tilling, C.: A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead-time’ approach. Health Econ. 20(3), 348–361 (2011)PubMedCrossRef
14.
go back to reference Oppe, M.: EuroQol Group’s international protocol for the valuation of the EQ-5D-5L (2012) Oppe, M.: EuroQol Group’s international protocol for the valuation of the EQ-5D-5L (2012)
Metadata
Title
Lead versus lag-time trade-off variants: does it make any difference?
Authors
Federico Augustovski
Lucila Rey-Ares
Vilma Irazola
Mark Oppe
Nancy J. Devlin
Publication date
01-07-2013
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue Special Issue 1/2013
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-013-0505-0

Other articles of this Special Issue 1/2013

The European Journal of Health Economics 1/2013 Go to the issue